Harvard Medical professor wins Berggruen Prize for transforming perception of infectious diseases

NewsGuard 100/100 Score

Paul Farmer, the Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at Harvard Medical School, was selected as the winner of the 2020 Berggruen Prize for Philosophy and Culture.

The $1 million award, announced Dec. 16 by the Berggruen Prize Jury, is given annually to thinkers whose ideas have profoundly shaped human self-understanding and advancement in a rapidly changing world. Farmer was chosen for his impactful work at the intersection of public health and human rights.

We are proud to award Dr. Paul Farmer the Berggruen Prize for Harvard Medical social inequality and caring for others while standing in solidarity with them. He has reshaped our understanding not just of what it means to be sick or healthy but also of what it means to treat health as a human right and the ethical and political obligations that follow."

Kwame Anthony Appiah, Chairman of Berggruen Prize Jury and Professor of Philosophy and law, New York University

Farmer is the author of twelve books written throughout a nearly thirty-year career in building lifesaving medical care systems in resource-poor communities, most notably in Haiti and West Africa. This lifetime of global health expertise has been instrumental in understanding and addressing the complexities of the coronavirus pandemic. Bringing vast experience from the Ebola outbreak in West Africa, he and his colleagues at Partners In Health designed and implemented the COVID-19 response in Massachusetts, centered around an intensive contact tracing program inclusive of resource coordinators to help people isolate safely. This approach was widely adopted by dozens of other states.

"As both thinker and actor, Dr. Paul Farmer has connected the philosophical articulation of human rights to the practical pursuit of health," said Nicolas Berggruen, chairman of the Berggruen Institute. "He has done this on the basis of new ideas and new analyses and also by connecting the human experience and practical politics of health to enduring challenges of human rights and justice. Not least, he has led by impressive moral example as an educator, a leader and a physician."

As the fifth winner of the prize, Farmer was selected from hundreds of nominees including some of the world's most renowned thinkers spanning the fields of philosophy, social science, global justice, bioethics and beyond, the institute announced.

In both theory and practice, Farmer has worked to change how the world thinks about health and disease. In AIDS and Accusation, Farmer addressed how disease was entangled with place and social relations by examining the profoundly interactive effects of social structure and biology.

Farmer remained active in the struggle against AIDS, breaking new ground in linking analysis of gender, drugs and poverty. His lifelong commitment to Haiti is manifest both in his medical practice and in Haiti after the Earthquake, which remains among the most important analyses of when international assistance works and when it doesn't.

In Pathologies of Power, Farmer connected the struggle for better health to the pursuit of human rights bringing a crucial new dimension to our understanding of global public health which is also evident in his newest book, Fevers, Feuds, and Diamonds: Ebola and the Ravages of History.

In 1983, he began his lifelong commitment to Haiti while still a student working with dispossessed farmers in Haiti's Central Plateau. He served there for ten years as medical director of a charity hospital, Good Savior Hospital. As a co-founder of Partners In Health, Farmer has led colleagues working in twelve sites throughout Haiti and twelve additional countries for the past 26 years. Founded in 1987, Partners in Health has become a model for health care for poor communities worldwide and provides the basis for developing a science of global health delivery implementation.

"Most recently, Dr. Farmer demonstrates how best to address this pandemic and prevent future ones. Dr. Farmer's call to improve public health systems is a matter not only of science but also of politics, economics, and ethics," said Amy Gutmann, Berggruen prize juror and president of the University of Pennsylvania. "In this crisis, like the ones that preceded it, our knowledge far outpaces our will to put effective solutions into action. Farmer has shown that health and health care disparities worsen the pandemic, and he calls for the social as well as medical support needed by all communities ravaged by coronavirus. He also emphasizes--while doing all in his own power to address--the special burden of caregivers. And he helps explain why, for all its importance, the arrival of vaccines will not replace the need for basic public health measures."

Farmer is a member of the National Academy of Medicine and the American Academy of Arts and Sciences and recently served as the United Nations special adviser to the secretary-general on community-based medicine and lessons from Haiti. Farmer is also HMS professor of medicine and chief of the Division of Global Health Equity at Brigham and Women's Hospital.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease